This inventor holds 1 USPTO granted patent. Top assignees: Biomarin Pharmaceutical Inc., Scripps Research Institute. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2009
Title: Woomi Kim: Innovator in Biochemical Therapeutics
Introduction
Woomi Kim is a notable inventor based in Busan, South Korea. He has made significant contributions to the field of biochemistry, particularly in the development of therapeutic proteins. His work focuses on addressing health issues related to phenylalanine imbalances in the human and animal body.
Latest Patents
Woomi Kim holds a patent for "Variants and chemically-modified variants of phenylalanine ammonia-lyase." This invention pertains to the use of the protein phenylalanine ammonia-lyase and its biologically-active derivatives for preventing or treating diseases associated with phenylalanine imbalances. The patent outlines therapeutic compositions that include a pharmaceutically active amount of these molecules, as well as methods for selecting more therapeutically effective variants of the protein.
Career Highlights
Throughout his career, Woomi Kim has worked with prestigious organizations such as the Scripps Research Institute and BioMarin Pharmaceutical Inc. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative therapeutic solutions.
Collaborations
Woomi Kim has collaborated with notable professionals in his field, including Marianne Patch and Emilio Kakkis. These collaborations have further enriched his research and expanded the impact of his inventions.
Conclusion
Woomi Kim's contributions to the field of biochemistry, particularly through his patent on phenylalanine ammonia-lyase, highlight his role as an innovator in therapeutic solutions. His work continues to pave the way for advancements in treating biochemical imbalances.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile